DOLOSPASMYL 60 mg/300 mg, soft capsule 40 capsules
Active ingredients: Alverine citrate, Simethicone
Commercialized according to BDPM
Soft capsule40 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOLOSPASMYL 60 mg/300 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 40 capsule(s)
- Marketing authorisation holder
- LABORATOIRES MAYOLY SPINDLER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Oct 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60252027CIP73003686CIP133400930036860Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CITRATE D'ALVÉRINEcapsule | 60 mg · une capsule | SA |
| SIMÉTICONEcapsule | 300 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.